Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805]).
Journal: Clinical genitourinary cancer
Published: January 05, 2017
National Institute on Aging /Alzheimer's Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors.
Journal: Journal of oncology research
Published: January 01, 2017
A phase II study of sorafenib, oxaliplatin, and 2 days of high-dose capecitabine in advanced pancreas cancer.
Journal: Cancer chemotherapy and pharmacology
Published: April 25, 2015
A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
Journal: Journal of cancer survivorship : research and practice
Published: January 20, 2015
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
Journal: Investigational new drugs
Published: November 13, 2012
A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261.
Journal: Gynecologic oncology
Published: February 23, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026